Insider digest · MRK
Merck insider filings, Oct 1, 2026
Merck insiders filed 3 routine Form 4 reports on Oct 1, 2026: awards. None of them was a purchase or a sale in the market. This page groups them in one place; each row links to the filing note, and each number links to the Form 4 itself.
What the codes mean: how to read a Form 4 · stock-based compensation.
Stock awards and grants
Shares or units the company granted as pay. No shares were bought or sold in the market. Total for the day: 374 shares or units, worth about $54,375 at the prices reported.
| Person | Code | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Mary Ellen Coe · director | A | Phantom Stock | 206.455 | $145.31 | $30,000 | 32,420 |
| Surendralal Lanca Karsanbhai · director | A | Phantom Stock | 111.830 | $145.31 | $16,250 | 5,667 |
| Christine E. Seidman · director | A | Phantom Stock | 55.915 | $145.31 | $8,125 | 21,490 |
The filings
- Merck director Mary Ellen Coe reports an award of about 206 phantom Stocks · SEC filing index
- Merck director Surendralal Lanca Karsanbhai reports an award of about 112 phantom Stocks · SEC filing index
- Merck director Christine E. Seidman reports an award of about 56 phantom Stocks · SEC filing index
Merck company file → · All Merck filings notes
Disclosures
- Editor holdings in MRK
- The editor holds no position in Merck (MRK). As of Nov 11, 2026.
- Compensation
- Nobody paid for this page. No affiliate links.
A summary of public filings for general education, the same for every reader. Not a recommendation to buy, sell or hold MRK.